All FDA/CDER/FOI archived FDA drug approval review and correspondence documentation since 1938, as well as an EMA EPAR document database, PharmaPendium offers you unrivalled insights into the entire history of drug development.

PharmaPendium includes the following content sources:

• FDA Approval Packages – allowing you to search through more than 1,3500,000 pages of information and experimental data including reviews, labels and other data.
• European Medicines Agency's (EMA) European Public Assessment Reports (EPARs) - 80,000 pages of searchable EPAR documents on EMA-approved drugs, including over 50 drugs/mixtures not approved by the FDA.
• Adverse Event Reporting System (AERS).
• Meyler's Side Effects of Drugs, 15th edition with over 40,000 references.
• Extracted metabolite data from literature.
• Extracted pre-clinical and clinical toxicity data.
• Extracted toxicity data from literature, from a pool of over 3,000 journals and other global sources.
• Target information.

And with FDA Classic Collection, FDA FOI drug approval documents prior to 1992 are now indexed and fully searchable.

The addition of the FDA classic collection means that PharmaPendium now has complete coverage of approved drugs since records began, so you don’t miss a thing. And for the first time in over 50 years you can scour the available biology and chemistry data on these older drugs.